featured
Improved Response Times With Bosutinib vs Imatinib in Newly Diagnosed CML
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Bosutinib Versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia: Results From the Randomized BFORE Trial
J. Clin. Oncol 2017 Nov 01;[EPub Ahead of Print], JE Cortes, C Gambacorti-Passerini, MW Deininger, MJ Mauro, C Chuah, DW Kim, I Dyagil, N Glushko, D Milojkovic, P le Coutre, V Garcia-Gutierrez, L Reilly, A Jeynes-Ellis, E Leip, N Bardy-Bouxin, A Hochhaus, TH BrümmendorfFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.